Did Patent Lawsuit Just Shift First Solar (FSLR) Investment Narrative?

• First Solar has filed a patent infringement lawsuit in U.S. federal court against JA Solar and Corning unit American Panel Solutions, claiming unauthorized use of its TOPCon crystalline silicon solar panel manufacturing technology acquired through the 2013 TetraSun deal.
• The case highlights how First Solar is looking to convert its TetraSun based intellectual property into licensing revenue, while signaling a willingness to defend panel efficiency related know how across international markets.
• This article examines how First Solar's investment narrative is affected by this TOPCon patent lawsuit and its intellectual property focus.

Scan how First Solar's patent play fits into the wider renewables race by lining it up against a curated 43 power grid technology and infrastructure stocks.

First Solar Investment Narrative Recap

To own First Solar, you need to believe this manufacturer can keep turning its thin film technology, CuRe rollout, and large contracted backlog into steady module shipments while managing cost friction. The TOPCon lawsuit sits alongside that story rather than in front of it. The most important near term swing factor still appears to be how effectively management fills and redirects Malaysia and Vietnam capacity.

Underutilization at those overseas plants and higher U.S. freight expenses remain the biggest operational overhang. The new patent case may add legal costs, but it does not clearly change that core risk. In practical terms, it suggests that First Solar is relying on intellectual property to protect efficiency advantages and potential licensing income without altering the existing production roadmap.

With no new operational announcements tied directly to this lawsuit, the most relevant existing development remains the CuRe technology rollout across Series 6 and 7 through the first half of 2028. That program supports expectations for performance based adjuster revenue that clusters in 2027 and 2028. It also ties back to why First Solar is protective of efficiency related IP in court.

For you as a shareholder, the link is straightforward. CuRe execution and the roughly 45.1 GW contracted backlog provide the main visibility on volumes and margins. Legal actions around TOPCon relate to safeguarding that broader technology edge rather than replacing those drivers. The key watch points remain utilization, U.S. trade rules, and on time delivery of the CuRe roadmap.

First Solar's narrative projects US$6.9b revenue and US$3.0b earnings by 2029. This assumes 8.5% yearly revenue growth and an earnings increase of about US$1.3b from US$1.7b today.

Uncover why First Solar's fair value indicates a 53% potential upside to its current price, which could narrow quickly.

Exploring Other Perspectives

For a very different angle, focus on how bullish analysts treat First Solar's patent portfolio as a potential earnings lever rather than a cost risk. Before this lawsuit, the most optimistic forecasts already pencilled in about US$7.5b revenue and US$4.4b earnings by 2029. You can assume those views might shift as the TOPCon case unfolds, so it is worth comparing several narratives before deciding how you feel about the stock.

Explore 6 other First Solar fair value estimates, including one that suggests as much as 106% potential upside from the current price.

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your First Solar research is our analysis highlighting 4 key rewards that could impact your investment decision.
• See our latest analysis for First Solar. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate First Solar's overall financial health at a glance.

Looking For More Investment Ideas Beyond First Solar?

If the First Solar story has sharpened your thinking, broaden your watchlist by scanning other stocks that match specific qualities using the Simply Wall St Screener.

• For investors who want potential mispricings with solid fundamentals, start with a curated group of 29 high quality undervalued stocks and see which ones deserve a closer look.
• If capital preservation and fewer surprises matter most to you, filter for companies in the 31 resilient stocks with low risk scores and focus on those with steadier risk profiles.
• When you are hunting for strong balance sheets and resilient business models, zero in on the list of solid balance sheet and fundamentals (25 results) to see which stocks fit that brief.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com